Modular Medical Expands Pivot Pump Access Through U.S. PBM Contract
San Diego, California — September 4, 2026 Modular Medical announced that it has secured a contract with a national...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
San Diego, California — September 4, 2026 Modular Medical announced that it has secured a contract with a national...
ABBOTT PARK, Ill., August 25, 2026 Abbott announced that the U.S. Food and Drug Administration (FDA) has authorized Libre...
ACTON, Mass., July 6, 2026 Insulet Corporation announced the commercial launch of its Omnipod® 5 Automated Insulin Delivery System...
SAN DIEGO, June 5, 2026 Tandem Diabetes Care announced that its t:slim X2 and Tandem Mobi automated insulin delivery...
RUTHERFORD, N.J., May 7, 2026 Glucotrack, Inc. announced the submission of an Investigational Device Exemption (IDE) application to the...
ACTON, Mass., May 4, 2026 Insulet Corporation has announced the enrollment of the first patient in its EVOLVE pivotal...
RUTHERFORD, N.J., March 27, 2026 GlucoTrack announced plans to submit an Investigational Device Exemption (IDE) application to the U.S....
BARCELONA, Spain, March 14, 2026 New real-world evidence presented at the 19th International Conference on Advanced Technologies & Treatments...
Rutherford, New Jersey | December 30, 2025 — Glucotrack, Inc., a medical technology company focused on diabetes care innovation,...
